Noninferiority of three monthsversussix months of oxaliplatin‐based adjuvant chemotherapy for resected colon cancer. How shouldIDEAfindings affect clinical practice?-Reference-Cited by-同舟云学术

Noninferiority of three monthsversussix months of oxaliplatin‐based adjuvant chemotherapy for resected colon cancer. How shouldIDEAfindings affect clinical practice?

Published:2018-08-11 Issue:10 Volume:143 Page:2342-2350
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int J Cancer

Author:

Formica Vincenzo¹^ORCID,Zaniboni Alberto²,Loupakis Fotios³,Roselli Mario¹

Affiliation:

1. Medical Oncology Unit, Department of Systems MedicineTor Vergata University HospitalRome Italy

2. Oncology DepartmentPoliambulanza FoundationBrescia Italy

3. Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico VenetoIRCCSPadua Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31616

Reference52 articles.

1. Geographic Variation and Sociodemographic Disparity in the Use of Oxaliplatin-Containing Chemotherapy in Patients With Stage III Colon Cancer

2. Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin‐based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): the IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration;Shi Q;J Clin Oncol,2017

3. Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin‐based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): updated results of IDEA (International Duration Evaluation of Adjuvant chemotherapy);Grothey A;Ann Oncol,2017

4. Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

5. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancer;International Journal of Cancer;2022-06-21

2. Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients;Annals of Coloproctology;2021-10-31

3. KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis;JNCI: Journal of the National Cancer Institute;2021-09-20

4. MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer;Life Sciences;2020-09

5. Doxorubicin metabolism moderately attributes to putative toxicity in prodigiosin/doxorubicin synergism in vitro cells;Molecular and Cellular Biochemistry;2020-08-04